1. Home
  2. WST

as of 12-10-2025 3:59pm EST

$266.99
+$0.92
+0.35%
Stocks Health Care Medical/Dental Instruments Nasdaq

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Chart Type:
Time Range:
Founded: 1923 Country:
United States
United States
Employees: N/A City: EXTON
Market Cap: 20.2B IPO Year: N/A
Target Price: $346.78 AVG Volume (30 days): 631.7K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
0.33%
Dividend Payout Frequency: Quarterly
EPS: 6.75 EPS Growth: 0.17
52 Week Low/High: $187.43 - $348.90 Next Earning Date: 10-23-2025
Revenue: $3,017,900,000 Revenue Growth: 4.92%
Revenue Growth (this year): 7.01% Revenue Growth (next year): 6.20%

AI-Powered WST Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 69.80%
69.80%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest West Pharmaceutical Services Inc. News

WST Breaking Stock News: Dive into WST Ticker-Specific Updates for Smart Investing

All WST News

Share on Social Networks: